LYEL
Price
$9.38
Change
-$0.14 (-1.47%)
Updated
Jul 18, 02:02 PM (EDT)
Capitalization
140.97M
19 days until earnings call
QSI
Price
$1.76
Change
-$0.06 (-3.30%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
367.09M
18 days until earnings call
Interact to see
Advertisement

LYEL vs QSI

Header iconLYEL vs QSI Comparison
Open Charts LYEL vs QSIBanner chart's image
Lyell Immunopharma
Price$9.38
Change-$0.14 (-1.47%)
Volume$100
Capitalization140.97M
Quantum-Si
Price$1.76
Change-$0.06 (-3.30%)
Volume$27.11K
Capitalization367.09M
LYEL vs QSI Comparison Chart in %
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. QSI commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and QSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (LYEL: $9.52 vs. QSI: $1.82)
Brand notoriety: LYEL and QSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 16% vs. QSI: 63%
Market capitalization -- LYEL: $140.97M vs. QSI: $367.09M
LYEL [@Biotechnology] is valued at $140.97M. QSI’s [@Biotechnology] market capitalization is $367.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileQSI’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • QSI’s FA Score: 0 green, 5 red.
According to our system of comparison, QSI is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 3 TA indicator(s) are bullish while QSI’s TA Score has 2 bullish TA indicator(s).

  • LYEL’s TA Score: 3 bullish, 4 bearish.
  • QSI’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, LYEL is a better buy in the short-term than QSI.

Price Growth

LYEL (@Biotechnology) experienced а -2.56% price change this week, while QSI (@Biotechnology) price change was +0.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.33%. For the same industry, the average monthly price growth was +13.96%, and the average quarterly price growth was +35.38%.

Reported Earning Dates

LYEL is expected to report earnings on Aug 06, 2025.

QSI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+3.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QSI($367M) has a higher market cap than LYEL($141M). LYEL YTD gains are higher at: -25.625 vs. QSI (-32.593). QSI has higher annual earnings (EBITDA): -105.87M vs. LYEL (-204.02M). LYEL has more cash in the bank: 301M vs. QSI (233M). QSI has less debt than LYEL: QSI (12.1M) vs LYEL (48.9M). QSI has higher revenues than LYEL: QSI (3.44M) vs LYEL (65K).
LYELQSILYEL / QSI
Capitalization141M367M38%
EBITDA-204.02M-105.87M193%
Gain YTD-25.625-32.59379%
P/E RatioN/AN/A-
Revenue65K3.44M2%
Total Cash301M233M129%
Total Debt48.9M12.1M404%
TECHNICAL ANALYSIS
Technical Analysis
LYELQSI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JHIUF26.640.64
+2.47%
James Hardie Industries plc
KXSCF146.001.46
+1.01%
Kinaxis, Inc.
ECNCF2.20N/A
N/A
ECN Capital Corp.
RRSFF0.01N/A
N/A
Aretto Wellness Inc.
BCTF12.15-0.11
-0.90%
Bancorp 34, Inc.

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-0.10%
VCYT - LYEL
46%
Loosely correlated
-3.77%
ZNTL - LYEL
42%
Loosely correlated
+3.60%
CRBU - LYEL
41%
Loosely correlated
N/A
BEAM - LYEL
39%
Loosely correlated
+1.89%
TYRA - LYEL
39%
Loosely correlated
-0.55%
More